Background: 1α,25-Dihydroxyvitamin D [1, 25(OH) 2 vitD] is the bioactive form of vitamin D. Due to the very low concentrations of 1,25(OH) 2 vitD in the blood and its lipophilic character, measurement of this parameter is analytically challenging. Requiring preceding manual extraction steps before analysis, previous assays have been laborious. Methods: In the presented study, we evaluated the performance of two immunoassays from DiaSorin and from Immunodiagnostic Systems (IDS) which combine fully automated extraction and measurement of 1,25(OH) 2 vitD. Imprecision and linearity were verified according to Clinical and Laboratory Standards Institute EP15-A3 and EP6-A guidelines, respectively. Ninety-three patient serum samples sent to our institute for determination of 1,25(OH) 2 vitD, as well as 20 Vitamin D External Quality Assessment Scheme (DEQAS) samples, were used to evaluate correlation and agreement of 1,25(OH) 2 vitD measurements between the two immunoassays and with liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Results: Total imprecision was 5.2% or less for the DiaSorin test but reached 20.1% for the IDS iSYS test. 1,25(OH) 2 vitD concentrations measured with the DiaSorin assay showed a strong correlation with 1,25(OH) 2 vitD levels measured by LC-MS/MS and a good agreement with method specific means of DEQAS samples. By contrast, the IDS iSYS test overestimated 1,25(OH) 2 vitD concentrations in human serum, particularly at higher concentrations.
Introduction
1α,25-Dihydroxyvitamin D [1,25(OH) 2 vitD], the active form of vitamin D, is synthesized by mitochondrial 25-hydroxyvitamin D-1α-hydroxylase in the kidney and in extrarenal tissues. In addition to the kidney, particularly diseaseactivated tissue macrophages and the placenta may contribute to circulating concentrations of 1,25(OH) 2 vitD [1] . 1,25(OH) 2 vitD mediates actions generally ascribed to vitamin D including the absorption of calcium and phosphorus from the intestine, the retention of calcium from the kidney and bone mineralization, thereby preventing rickets and osteomalacia. Recently observed associations of low vitamin D levels with increased risks of cardiovascular diseases [2] [3] [4] , type 2 diabetes [5] , autoimmune diseases [6] , infections of the upper respiratory tract [7] , neurodegenerative disease [8] , as well as breast or colorectal cancer [9, 10] point to extraskeletal actions of vitamin D. The expanded knowledge of the relevance of sufficient vitamin D levels is reflected by an experienced increased demand for the determination of vitamin D status in patients.
Although 1,25(OH) 2 vitD is less suitable than 25-hydroxyvitamin D [25(OH) vitD] to assess vitamin D status, there are some indications to specifically determine 1,25(OH) 2 vitD serum levels. This mainly includes differential diagnosis of hypercalcemia in patients with sarcoidosis and other granulomatous diseases. Determination of 1,25(OH) 2 vitD can also be useful in patients with unexplained hyperparathyroidism who have adequate 25(OH) vitD levels. 1,25(OH) 2 vitD is particularly suitable to differentiate between two hereditary defects namely vitamin D-dependent rickets (VDDR) type I, caused by vitamin D 1α-hydroxylase deficiency, and VDDR type II, caused by mutation of the vitamin D receptor gene leading to end-organ resistance to vitamin D. The growing knowledge of the prognostic significance of 1,25(OH) 2 vitD after cardiac surgery and in sepsis and heart failure [11] [12] [13] will further increase the medical need to analyze 1,25(OH) 2 vitD.
Due to its low concentration (pmol/L) and lipophilic nature, the quantification of 1,25(OH) 2 vitD in serum is analytically challenging and requires extraction and separation steps prior to measurement. So far, mainly radioimmunoassays have been used for the measurement of 1,25(OH) 2 vitD. They measure this parameter with sufficient sensitivity but are laborious, time consuming and prone to laboratory error associated with manual handling of the probes. The first automated assay including manual extraction had been developed by Immunodiagnostic Systems (IDS) Ltd., using the IDS iSYS immunoanalyzer. Recently, two assays became commercially available, which include not only the automated measurement but also an automated extraction of 1,25(OH) 2 vitD prior to quantification. In this study, we evaluated and compared the performance of these two fully automated assays with each other and with liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
The measurement of 1,25(OH) 2 vitD is poorly standardized. Whereas for the standardization of 25(OH) vitD measurements, a reference measurement procedure as well as National Institute of Standards and Technology standard reference material is available [14, 15] , for 1,25(OH) 2 vitD, a lot of work remains to be done to render the results from different laboratories and methods comparable. The Vitamin D External Quality Assessment Scheme (DEQAS) supports this standardization process by providing external quality control material not only for 25(OH) vitD but also for 1,25(OH) 2 vitD. We therefore compared the values measured using the fully automated assays with the results obtained by DEQAS.
Materials and methods

Samples
Remaining material of 142 patient serum samples submitted to the Institute of Clinical Chemistry of the University Hospital Zurich for routine measurement of 1,25(OH) 2 vitD was aliquoted and stored at − 80 °C until analysis. All samples with extensive hemolysis, bilirubinemia or lipemia were excluded from the study. For analysis with the different tests, serum samples were thawed and one aliquot each was analyzed according to the manufacturer's instructions. Of 93 samples, sufficient serum material was available for measurement of 1,25(OH) 2 vitD concentrations using a LC-MS/MS based method.
Only samples of patients aged 18 years or older were included in the study. The study has been approved by the Zurich Cantonal Ethical Committee. 2 vitD antibody. Thus, the resulting signal is inversely proportional to the amount of the analyte in the probe.
Immunoassays
The performance characteristics of the immunoassays are outlined in Table 1 .
Mass spectrometry
For measurement of 1,25(OH) 2 vitD with LC-MS/MS, aliquots were shipped on dry ice to the laboratory of Prof. Hoofnagle at the University of Washington (Seattle, WA, USA). 1,25(OH) 2 vitD2 and 1,25(OH) 2 vitD3 serum concentrations were measured there as previously described [17] .
Imprecision and accuracy
Assay imprecision has been estimated according to Clinical and Laboratory Standards Institute (CLSI) EP15-A3 guidelines [18] . Manufacturers' quality control material as well as patient serum samples have been analyzed over 5 days with five measurements a day. From the obtained 25 measurements, within-run, between-run, and total imprecision have been estimated.
Linearity
Serial dilutions of a sample with high 1,25(OH) 2 vitD concentration have been prepared using serum with very low or even non-measureable low levels as diluent in order to cover the measurement range of the tests. 1,25(OH) 2 vitD concentrations were determined in duplicates and measured serum concentrations were compared to expected concentrations. Polynomial regression analysis has been used for the assessment of linearity according to the National Committee on Clinical Laboratory Standards (NCCLS) EP6-A evaluation protocol [19] . A linear or non-linear coefficient was assumed to be statistically significant if p was < 0.05.
Method comparison
Frozen aliquots were thawed and equilibrated to room temperature. Samples were mixed gently and analyzed in batches on the IDS iSYS and the LIAISON XL immunoanalyzer. Quality control samples were analyzed together with each batch of samples to monitor the performance of the assays and the instruments. Correlation and agreement between the tested methods were assessed by means of Passing-Bablok regression analysis [20] , Bland-Altman difference plots [21] , and determination of Pearson's coefficient of correlation. For correlation analysis, samples below the lower limit of the measurement range were assigned the value of the lower limit (7.5 and 5.0 ng/L for the IDS test and the DiaSorin test, respectively).
Statistical analysis
All statistical analyses were performed using Analyse-it, a statistical software for Microsoft Excel (Analyse-it Software Ltd.)
Results
Imprecision and accuracy
For the determination of imprecision, quality control material available from the respective manufacturer as well as human serum pools were analyzed according to the CLSI EP15-A3 guidelines. Imprecision results from a total of 25 measurements of each probe are shown in Table 2 .
The DiaSorin test determined 1,25(OH) 2 vitD very precisely, with total imprecision ranging between 3.1% and 5.2% and hence within the range of 3.6%-6.6% reported by the manufacturer. In contrast, the total imprecision of the IDS test ranged between 7.1% and 20.1%. Intra-and inter-assay imprecisions were between 5.6% and 19.8% and between 3.5% and 15.3%, respectively, as compared to intra-assay and inter-assay imprecisions reported by the manufacturer, being 6.4%-12.1% and 4.6%-9.6%, respectively. However, for the imprecision determined by the manufacturer, only serum samples with concentrations of 25.3 ng/L and above have been investigated. Furthermore, we found that the DiaSorin test measured 1,25(OH) 2 vitD concentrations with better accuracy than the IDS test, namely with a bias of 2.5% and − 0.1% as compared to 21.3% and 14.1%.
Linearity
A series of dilutions was prepared by adding different amounts of serum with very low or non-measurable low 1,25(OH) 2 vitD concentrations to a serum sample with high 1,25(OH) 2 vitD concentrations. Within the measurement ranges either test showed good correlations between measured and expected 1,25(OH) 2 vitD concentrations ( Figure 1 ). Statistical analysis revealed that none of the non-linear coefficients was statistically significant. Thus, for the IDS test as well as the DiaSorin test a linear equation models the data best. Reflecting the high imprecision, the IDS test showed poorer agreement between duplicate measurements.
Method comparisons Correlation and agreement between the immunoassays
One hundred forty-two serum samples, sent for routine analysis of 1,25(OH) 2 Figure 2E) . Moreover, the IDS test overestimated 1,25(OH) 2 vitD serum concentrations especially in the higher concentration range, whereas the DiaSorin test showed good agreement. In the Bland-Altman analysis mean bias was 7.0% (95% LoA, − 69.8% and 83.9%) for the IDS test but only 2.3% (95% LoA, − 29.2% and 33.7%) for the DiaSorin test ( Figure 2D, F) .
Unlike the immunoassays, LC-MS/MS can distinguish between 1,25(OH) 2 vitD2 and 1,25(OH) 2 vitD3. The majority of the samples had very low 1,25(OH) 2 vitD2 levels, only 6 of the 93 samples with total 1,25(OH) 2 vitD concentrations between 7.8 and 85.1 ng/L measured with LC-MS/MS contained 5% or more 1,25(OH) 2 vitD2. One of these Mean deviations of the IDS and DiaSorin measurement results from the mean of LC-MS/MS measurements were 2.1% and 1.8%, respectively. However, individual measurements with the IDS test deviated more strongly from the LC-MS/MS method (range, − 51% to 50%) than measurements with the DiaSorin test (− 20% to 26%), reflecting the higher imprecision of the IDS test as seen in the method comparison and the imprecision study (Figure 3) .
Discussion
In the presented study, we evaluated the analytical performance of two new commercially available fully automated assays for the measurement of 1,25(OH) 2 vitD. Both immunoassays allow for determination of 1,25(OH) 2 vitD within a shorter time frame compared to radioimmunoassays and other tests with manual sample pretreatment. Overall, the DiaSorin test performed better in terms of accuracy, sensitivity and imprecision compared to the IDS iSYS test.
The DiaSorin test running on the LIAISON XL analyzer measured 1,25(OH) 2 vitD with good sensitivity and high reliability. Precision was very good even in the low concentration range and comparable to precision values previously described. Van Helden and Weiskirchen 2 vitD, the IDS test purifies the analyte from the serum using an anti-1,25(OH) 2 vitD antibody. One might argue that the fusion protein binds to 1,25(OH) 2 vitD with higher specificity than the antibody, leading to the lower imprecision and the better correlation with LC-MS/MS of the DiaSorin test. However, our currently used IDS test with manual extraction of 1,25(OH) 2 vitD shows significantly stronger correlation with the LC-MS/MS measurements than the fully automated IDS test (r = 0.908 vs. r = 0.852, Figure 4 ), although this was still weaker than that of the DiaSorin test (r = 0.967). Assuming that the same antibody is used for the manual and automated extraction prior to measurement of 1,25(OH) 2 vitD, the automated extraction steps of the IDS test need to be optimized.
1,25-Dihydroxyvitamin D2 is derived from dietary ergocalciferol, which is subsequently 25-hydroxylated in the liver and 1α-hydroxylated in the kidney. Both, vitamins D2 and D3 are comparably biologically active [23] . In order to correctly represent the biologically relevant amounts, the tests used for the determination of 1,25(OH) 2 . This is in accordance with the manufacturer's data for the DiaSorin test. For the IDS test, a cross-reactivity of 57% is indicated by the manufacturer, but the respective tested concentration is not indicated. In our study, we only had six samples with 1,25(OH) 2 vitD2 concentrations above 5% of total 1,25(OH) 2 vitD. Further studies involving more samples with significantly elevated 1,25(OH) 2 vitD2 levels are necessary to precisely evaluate the cross-reactivity of the tests with 1,25(OH) 2 vitD2. No or only very low crossreactivity is indicated by either manufacturer for vitamin D metabolites with less biological activity.
Measurement of 1,25(OH) 2 vitD using fully automated tests is of significant advantage, particularly as the number of samples submitted for the determination of this parameter has increased over the recent years. The implementation of such tests allows for higher throughput and less hands-on time compared to the manual tests used so far. Together with the high sensitivity, low imprecision, the broad measurement range and the good agreement with 1,25(OH) 2 vitD concentrations measured with LC-MS/MS, the DiaSorin test improves 1,25(OH) 2 vitD diagnostics. The fully automated test performed on the IDS iSYS has a comparable broad measurement range but needs further improvement with respect to sensitivity, precision and standardization. The respective limitations have most recently been addressed by the supplier by a further development of the test, for which the presented study will serve as an ideal starting point and framework for the evaluation of critical performance factors.
